Trial intelligence / Profile preview

In situ mineral change and fluoride retention with elmex gel vs placebo

2008-008594-58Phase 4Completed

Sponsor
Colgate-Palmolive
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Elmex Gelée in carious lesion (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Mineral change of sound and demineralized plaque-covered enamel and Progression of enamel demineralization. Started May 2009; status: completed.

02

Drugs

Elmex Gelée
03

Conditions

carious lesion

Beyond the preview

Go deeper on 2008-008594-58.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008594-58.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call